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Abstract: African Americans (AA) tend to have heightened systemic inflammation and
endothelial dysfunction. Endothelial microparticles (EMP) are released from activated/apoptotic
endothelial cells (EC) when stimulated by inflammation. The purpose of our study was to assess
EMP responses to inflammatory cytokine (TNF-α) and antioxidant (superoxide dismutase,
SOD) conditions in human umbilical vein ECs (HUVECs) obtained from AA and Caucasians.
EMPs were measured under four conditions: control (basal), TNF-α, SOD, and TNF-α + SOD.
Culture supernatant was collected for EMP analysis by flow cytometry and IL-6 assay by ELISA.
IL-6 protein expression was assessed by Western blot. AA HUVECs had greater EMP levels
under the TNF-α condition compared to the Caucasian HUVECs (6.8 ± 1.1 vs 4.7% ± 0.4%,
P = 0.04). The EMP level increased by 89% from basal levels in the AA HUVECs under the
TNF-α condition (P = 0.01) compared to an 8% increase in the Caucasian HUVECs (P = 0.70).
Compared to the EMP level under the TNF-α condition, the EMP level in the AA HUVECs
was lower under the SOD only condition (2.9% ± 0.3%, P = 0.005) and under the TNF-α +
SOD condition (2.1% ± 0.4%, P = 0.001). Basal IL-6 concentrations were 56.1 ± 8.8 pg/mL/µg
in the AA and 30.9 ± 14.9 pg/mL/µg in the Caucasian HUVECs (P = 0.17), while basal IL-6
protein expression was significantly greater (P , 0.05) in the AA HUVECs. These preliminary
observational results suggest that AA HUVECs may be more susceptible to the injurious effects
of the proinflammatory cytokine, TNF-α.
Keywords: endothelium, inflammation, endothelial microparticles, African Americans

Endothelial dysfunction precedes hypertension and atherosclerosis1,2 and is a prognostic indicator of future cardiovascular events. In response to sensing hormonal,
biochemical, and mechanical stimuli, the endothelium releases mediators of vascular
function, initiates inflammatory processes, and influences homeostasis. In the US,
African Americans experience higher mortality from cardiovascular disease (CVD)
including hypertension compared to Caucasians or Mexican Americans.3
An impaired endothelium is conventionally thought to be analogous to diminished
nitric oxide (NO)-mediated vasodilation in response to endothelial NO synthase
(eNOS) agonists such as acetylcholine or bradykinin. Currently, there is an expanded
appreciation of endothelial dysfunction which includes a proinflammatory, pro-oxidant,
and prothrombic EC state. Several studies have shown that African-Americans have
impaired endothelial function as determined by flow-mediated dilation (FMD)4–6 and
other measures of endothelial-dependent vasodilation.7–12
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The mechanisms underlying racial disparities in CVD and
endothelial dysfunction are multifactorial, but could be due,
in part, to differences in endothelial cell (EC) responses to
stimuli. However, a major problem with research on the racial
disparity in endothelial dysfunction is that it is conducted
at the organ or clinical levels and not at the cellular level.
This lack of knowledge about the EC biology of African
Americans severely impedes advances in finding optimal
preventive and treatment strategies.
In response to proinflammatory cytokine stimulation,
ECs undergo functional changes that include increased
expression/production of IL-6 and adhesion molecules, and
induction of procoagulant activity.13–15 African Americans
have also been shown to have higher levels of inflammatory
markers compared to Caucasians and this also may contribute
to the greater CVD-related morbidity and mortality in this
population.16–21 Studies have linked inflammation to EC
activation, an early step in endothelial dysfunction, and loss
of NO bioactivity.22 In a cell culture study, Kalinowski et al
showed that human umbilical ECs (HUVECs) from African
Americans had reduced NO bioavailability compared to
Caucasian HUVECs primarily due to increased superoxide
(O2-) production and eNOS uncoupling.23
Endothelial microparticles (EMP) are submicroscopic
membranous particles that are released from activated or
apoptotic parent EC when stimulated by proinflammatory
cytokines, oxidative stress, or infectious agents.24 They carry
with them a subset of membrane proteins and phospholipids,
or markers, of their parent EC including those induced by
activation, apoptosis or oxidative stress. Recent evidence
indicates that EMPs provide valuable information about the
biological status of the endothelium. Previous studies have
shown that EMPs expressing constitutive surface markers
such as CD31 (platelet endothelial cell adhesion molecule;
PECAM) are increased in injury and/or apoptosis.25 Results
from both clinical and laboratory studies demonstrate that
higher EMP levels are related to diminished endotheliumdependent vasodilation. The level of EMP appears to correlate with the degree of endothelial dysfunction in patients
with chronic renal failure26 or coronary artery disease.27 Thus,
the level of EMPs is emerging as a novel direct marker of
EC impairment mediated by activation and apoptosis28,29
and may provide new insight into the mechanisms of racial
disparities in endothelial dysfunction. However, EMPs have
never been used to assess potential racial differences in
endothelial function.
Due to the hypothesized mechanisms leading to endothelial dysfunction and EC impairment in African Americans,
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the purpose of our study was to observe EMP responses to
inflammatory cytokine (TNF-α) and antioxidant (superoxide
dismutase, SOD) conditions in HUVECs obtained from
African Americans and Caucasians.

Methods
Human umbilical vein endothelial cells
HUVECs were purchased from Lonza Inc (Walkersville,
MD), who harvested ECs from umbilical cord donors (AA,
n = 3; Caucasian, n = 3). Cryopreserved HUVECs were then
shipped by Lonza as frozen primaries. The HUVECs were
cultured in parallel, in EGM medium supplemented with 2%
fetal bovine serum (FBS) and growth factors (Lonza, Inc) at
37°C in a 95% air -5% CO2 atmosphere, following methods
by Lonza. All Lonza HUVECs are characterized by morphological observation through serial passaging, positive test
for von Willebrand Factor VIII and acetylated low density
lipoprotein (LDL) uptake, and negative test for α-smooth
muscle actin.

Experimental procedures
Human recombinant TNF-α was purchased from Sigma
(St Louis, MO) and SOD was purchased from Worthington
Biochemical Corporation (Lakewood, NJ). Parallel HUVEC
cultures were tested under four separate conditions: Control,
TNF-α (100 U/mL) for 4 hours, SOD (100 U/mL) for
24 hours, and TNF-α + SOD. 100 U/mL of TNF-α was
selected because it is a typical level used to stimulate ECs
and falls approximately midway between the highest and
lowest levels used to stimulate ECs in similar studies.30–35
Culture media samples (4 mL) obtained from 106 ECs were
collected and immediately frozen at −80°C for subsequent
EMP analysis.25,36 Remaining culture supernatant was collected for IL-6 assay.
Cell lysate was collected by cellular fractionation for total
SOD activity measurements. Briefly, cells were washed once
with ice-cold phosphate buffer solution, and resuspended in
2 mL cold 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer (Lonza) using a rubber scraper. Cells
were centrifuged at 600g for 10 minutes at 4°C. The cell pellet was resuspended in 500 µL cold HEPES buffer and then
transferred to a Teflon glass homogenizer. The cell solution
was homogenized at 1600 rpm for 30 strokes while on ice,
and then immediately centrifuged at 1500g for 5 minutes at
4°C. Protein concentration was measured using the Bradford
method.
For all procedures, AA and Caucasian HUVECs at
passage 4 were treated identically. For assay, experimental
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samples were tested in duplicate and control samples of
culture media were tested along with the cell samples in
order to eliminate potential interference from culture media
in measurements. Absorbance was read using a SpectraMax
Microplate Reader (Molecular Devices, Sunnyvale, CA).

EMP immunolabeling
Microparticles express several different cell surface markers
which can be quantified. The preferred method is the 2-color
combination of phycoerythrin (PE)-labeled anti-CD31
with fluorescein isothiocyanate (FITC)-labeled anti-CD42.
Because CD31 is also found on platelets, platelet-specific
CD42 allows counting the platelet microparticles population (CD31+, CD42+) distinct from EMP (CD31+, CD42-),
giving both counts in a single run. This pair of markers has
the advantage of being very bright and therefore sensitive.29
EMP samples were prepared as previously described.37,38
To remove unwanted cellular fragments, thawed culture
media (1.5 mL) was centrifuged for 5 minutes at 4300g
(20°C). Supernatant was removed and transferred into a new
tube and centrifuged for 90 minutes at 3152g (20°C). 100 µL
of the supernatant was transferred to a new tube and incubated
with 20 µL of anti-human CD31+ (PE) and 20 µL of anti
CD42 (FITC) in the dark at room temperature (30 minutes),
then fixed by adding 93 µL of 10% formaldehyde. The
mixture was protected from light and incubated while being
gently mixed for 20 minutes using a shaker. Samples were
diluted in 500 µL of double-filtered (0.22 µm) PBS for a
total sample volume of 733 µL. Two additional tubes were
prepared to serve as a negative control and as a calibration.
For the negative control tube, 733 µL of PBS was added to one
tube. To prepare the calibrator sample, two drops of 0.9 µm
standard precision NIST traceable polystyrene particle beads
(Polysciences Inc, Warrington PA) were added to PBS according to the manufacturer’s instructions. All samples were then
immediately analyzed by flow cytometry.

Flow cytometry
Labeled EMP produced by 106 ECs were analyzed using an
LSRII flow cytometer (BD Biosciences, San Jose, CA) and analyzed with BD FACSDiva software (v 1.2.6; BD Biosciences).
There is no consensus on the threshold level setting which determines the smallest size microparticle analyzed, therefore we set
the threshold levels based on the number of background events
per second when double-filtered PBS was passed through the
flow cytometer as reported by Orozco and Lewis.39 The upper
limit of gate was determined by 0.9 µm standard beads. CD31+/
C42- events included in this gate were identified in forward and
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side scatter intensity dot representation and plotted on 2-color
fluorescence histograms and were considered EMP.5,40,41–43
From each 50 µL sample, the percentage of EMP from 50,000
total events was recorded.40,41 Before every run, the machine
was kept running until the background events fell to baseline
levels. The final EMP values were then expressed as % total
events40 normalized to protein content (µg/µL). The inter- and
intra-assay CVs were 8% and 6%, respectively.

Western blot for IL-6 protein
HUVECs were washed twice in ice-cold Hanks buffered
saline solution and lysed in Radio-Immunoprecipitation
Assay Buffer with Roche protease inhibitor (RIPA-Pi).
Phenylmethylsulfonyl fluoride protease inhibitor was also
added to the RIPA-Pi to eliminate interference. At confluence, cells were collected, centrifuged at 16,000g for
10 minutes at 4°C. Quantification of protein content was
measured by Bradford assay. 20 µg of protein was separated by electrophoresis through 10% SDS-polyacrylamide
gel. Proteins were then transferred to nitrocellulose filter
membranes. Membranes were blocked with non-fat dry milk
in Tris-buffered saline and incubated overnight with primary
antibodies at 4°C. Subsequently, the membranes were washed
and then incubated with secondary antibody conjugated
with horseradish peroxidase. Immunoreactive proteins were
detected by chemiluminescence with Thermo Scientific
SuperSignal substrate systems (Pierce Biotechnology).
Anti-IL-6 (Abcam, Inc, MA). Actin antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) was used as the internal
control. Band densitometry analysis was performed using
National Institutes of Health ImageJ software.

Assay for superoxide dismutase
(SOD) activity
Total SOD activity was measured in order to have an assessment of the cell’s potential for superoxide quenching. Total
SOD activity in cell lysate samples by assay (Cayman Chemical, Ann Arbor, MI), as previously reported.42 Concentrations
were normalized to protein content (µg/µL). Inter-assay and
intra-assay CVs were 5.9% and 12.4%, respectively.

Assay for IL-6
IL-6 proteins released into media were measured in cell
culture supernatants by ELISA (Thermo Scientific-Pierce
Biotechnology, Rockford, IL), according to manufacturer’s
instructions. Concentrations were normalized to protein
content (µg/µL). The intra- and inter-assay CVs were 9%
and 10%, respectively.
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All values were presented as means ± SE. Two-way
(ethnicity by condition) and one-way (within ethnicity and
within experimental condition) ANOVA followed by Fisher’s
protected least significant difference (PLSD) were performed
for statistical comparisons. An independent t-test was used
to compare band densities for IL-6 expression between AA
and Caucasian HUVECs. A P-value ,0.05 was considered
statistically significant.

Results
HUVEC morphology under
all experimental conditions

EMP levels under basal conditions
Figure 2 shows comparisons of EMP levels between AA
and Caucasian HUVECs under all experimental conditions.
African
American

Caucasian

Control

TNF-α

SOD

TNF-α + SOD

Figure 1 Representative images of African American and Caucasian HUVECs at
harvest under all experimental conditions.
Abbreviations: HUVEC, human umbilical vein endothelial cells; SOD, superoxide
dismutase; TNF-α, tissue necrosis factor alpha.
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ANOVA P = 0.06

7
6

*

5
4
3
2
1
0

Representative images of AA and Caucasian HUVECs at
confluency under all experimental conditions are shown
in Figure 1. HUVECs displayed a cobblestone-like shape.
There were no morphological differences between the AA
and Caucasian HUVECs.

Experimental
condition

Caucasian HUVECs
8

EMP (%/µg protein)
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Statistical analysis

Basal

SOD

TNF-α TNF-α + SOD

Figure 2 Comparison of EMP levels between the African American and Caucasian
HUVEC groups under each of the experimental conditions.
Note: *P , 0.05 between HUVEC racial groups.
Abbreviations: HUVEC, human umbilical vein endothelial cells; SOD, superoxide
dismutase, EMP, endothelial microparticles; ANOVA, analysis of variance.

There were no significant differences in EMP levels under
basal conditions between AA (3.6% ± 0.7%) and Caucasian
(4.4% ± 0.6%) HUVECs (P = 0.38).

Effects of TNF-α stimulation
and SOD on EMP generation
TNF-α is a potent inducer of inflammatory reactions and
oxidative stress in EC. When the levels of EMPs were analyzed by experimental condition (AA and Caucasian HUVEC
responses combined), TNF-α significantly increased EMP
from the basal level of 3.9% ± 0.4% to 5.7% ± 0.6% (P = 0.01).
Compared to the basal EMP level, SOD decreased the EMP
level to 3.0% ± 0.5% (P = 0.19). Compared to the TNF-α
condition, the addition of SOD significantly reduced the
EMP level to 3.0 ± 0.3 (P , 0.0001). The EMP levels under
the SOD only condition (3.0 ± 0.3) and the TNF-α + SOD
condition (2.6 ± 0.3) were not different.
The interactive effect of HUVEC race and experimental
condition was borderline significant (P = 0.06, Figure 2). Post
hoc analyses showed that AA HUVECs had a significantly
greater level of EMP under the TNF-α condition compared to
the Caucasian HUVECs (6.8 ± 1.1 vs 4.7% ± 0.4%, P = 0.04).
Within the AA HUVECs, the EMP level increased by 89%
from a basal level of 3.5 ± 0.7 to 6.8% ± 1.1% under the TNF-α
condition (P = 0.01) (Figure 3A). Compared to the EMP level
under the TNF-α condition, the EMP level was significantly
lower under the SOD only condition (2.9% ± 0.3%, P = 0.005)
and under the TNF-α + SOD condition (2.1% ± 0.4%,
P = 0.001). Within the Caucasian HUVECs, there was only
an 8% increase in the EMP level from the basal condition to
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African American HUVECs

A

African American HUVECs

P = 0.009
8

70

P = 0.005

SOD (U/mg)

EMP (%/µg protein)

4
3

0

*

40
30

†

20

0
TNF

Basal
Basal

B

SOD

TNF-α

TNF-α + SOD

Caucasian HUVECs
6
P = 0.05

5

P = 0.02

Figure 4 Total SOD activity under basal and TNF-α conditions in African American
and Caucasian HUVECs.
Notes: *P , 0.05 between HUVEC racial groups within condition; †P , 0.05
compared to TNF-α condition within racial HUVEC groups.
Abbreviations: HUVEC, human umbilical vein endothelial cells; SOD, superoxide
dismutase; TNF-α, tissue necrosis factor alpha.

caused a significant increase in SOD activity in the AA
HUVECs (P = 0.04), while no significant change occurred
with TNF-α stimulation in Caucasian HUVECs (P = 0.09).

4
3

IL-6 concentrations under
basal conditions

2
1
0

50

10

2
1

EMP (%/µg protein)
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5

*

60

P = 0.001

6

Caucasian HUVECs

Basal

SOD

TNF-α

TNF-α + SOD

Figure 3 A) EMP levels under each of the experimental conditions in African
American HUVECs. B) EMP levels under each of the experimental conditions in
Caucasian HUVECs.
Abbreviations: HUVEC, human umbilical vein endothelial cells; SOD, superoxide
dismutase, EMP, endothelial microparticles.

the TNF-α condition (P = 0.70) (Figure 3B). The only significant difference in EMP levels in the Caucasian HUVECs
was between the TNF-α (4.7% ± 0.4%) and the TNF-α + SOD
condition (3.0% ± 0.3%, P = 0.02). The difference in the level
of EMP between the TNF-α condition (4.7 ± 0.4) and the SOD
condition (3.2 ± 1.0) was borderline significant (P = 0.05).

Total SOD activity under basal
and TNF-α conditions
Total SOD activity in AA and Caucasian HUVECs under
basal and TNF-α conditions are shown in Figure 4. Basal
SOD activity levels were (17.2 ± 12.0 U/mg) in the AA
HUVECs and (35.8 ± 17.2 U/mg) the Caucasian HUVECs
(P = 0.03). Compared to the basal levels, TNF-α stimulation

Vascular Health and Risk Management 2011:7

IL-6 concentrations in AA and Caucasian HUVECs under
all experimental conditions are shown in Figure 5. Basal
IL-6 concentrations were (56.1 ± 8.8 pg/mL/µg) in the
AA HUVECs and (30.9 ± 14.9 pg/mL/µg) the Caucasian
HUVECs (P = 0.17). Given the nearly two-fold higher basal
IL-6 concentration in the AA HUVECs, we wanted to confirm
whether IL-6 protein expression was greater. Representative Western blots for IL-6 protein under basal conditions
are shown in Figure 5. Basal IL-6 protein expression was
significantly greater in the AA HUVECs compared to the
Caucasian HUVECs. This confirmed the greater basal IL-6
concentrations in the culture media of AA HUVECs.

Effects of TNF-α stimulation and SOD on
IL-6 concentrations and protein expression
The binding of TNF-α to its receptor on EC induces downstream gene expression of IL-6, which can influence EC
function and cause increased adhesion and chemokine
expression and apoptosis. When the levels of IL-6 were
analyzed by experimental condition (AA and Caucasian
HUVEC responses combined), IL-6 concentration increased
from 44.9 ± 8.8 pg/mL/µg protein under basal conditions
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Basal IL-6 expression
African American

P < 0.05

African American HUVECs
90

IL-6 (pg/mL/µg protein)
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Caucasian

80

Caucasian HUVECs
ANOVA P = 0.43

70
60
50
40
30
20
10
0

Basal

SOD

TNF-α TNF-α+ SOD

Figure 5 IL-6 concentrations under each of the experimental conditions in African
American and Caucasian HUVECs.
Notes: *P , 0.05 between HUVEC racial groups within condition; †P , 0.05
compared to TNF-α condition within racial HUVEC groups. At the top are
representative Western blots of basal IL-6 protein expression levels in African
American and Caucasian basal HUVECs.
Abbreviations: HUVEC, human umbilical vein endothelial cells; SOD, superoxide
dismutase; TNF-α, tissue necrosis factor alpha; ANOVA, analysis of variance.

to 62.6 ± 10.6 pg/mL/µg protein under TNF-α stimulation,
but the difference was not statistically significant (P = 0.14).
There were no significant differences in IL-6 concentrations
between any of the other conditions. The interactive effect of
HUVEC race and condition was not statistically significant
(P = 0.43) (Figure 5). Within the AA HUVECs, the IL-6 concentration under the SOD condition tended to lower compared
to the TNF-α condition (40.0 ± 8.0 vs 70.8 ± 15.7 pg/mL/µg,
P = 0.07) (Figure 5). Within the Caucasian HUVECs, there
were no significant differences in IL-6 concentrations between
any of the experimental conditions (Figure 4).

Discussion
The most important finding of this preliminary observational study was that for the first time we showed that
TNF-α-stimulated EMP generation was different between
African American and Caucasian HUVECs. AA HUVECs
demonstrated an 89% increase in EMP generation as a
result of TNF-α stimulation compared to an 8% increase
in EMP generation in the Caucasian HUVECS. This finding is important because it is generally thought that for any
given level of BP, African Americans have a greater degree
of endothelial dysfunction compared to Caucasians and
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because the measurement of the EMP expression of marker
CD31 is linked to EC activation/apoptosis. Therefore, these
observations suggest that AA HUVECs have greater EC
damage from TNF-α stimulation.
Microparticles are not released randomly into the
circulation.43 Activation or injury of the endothelium leads
to various inflammatory-related processes including the
release of microparticles. Combes et al were the first to
demonstrate that HUVECs release EMP when stimulated
with TNF-α. 24 Other proinflammatory, prothrombotic,
proapoptotic, or oxidative substances also induce the release
of EMP.28,44 EMP express adhesion molecules specific for
mature ECs such as CD54 (ICAM-1), CD62E (E-selectin),
CD62P (P-selectin), or CD31 (PECAM).28,29 CD31 is also
expressed by platelet-derived microparticles, therefore EMP
specificity is ensured by the CD31+/CD41- phenotype with
CD41 being the platelet integrin GPIIbIIIa.28,29 Studies have
demonstrated that EMP can be used as a novel biomarker of
endothelial injury that directly reflects the homeostatic state
of the endothelium.29,45–49 To our knowledge, no study has
used EMPs as an index of endothelial cell status to assess
potential racial differences in EC function.
TNF-α stimulation caused a significant 89% increase
in EMP level in AA HUVECs and a nonsignificant 8%
increase in EMP level in the Caucasian HUVECs. The EMP
levels under TNF-α stimulation were significantly different between the HUVEC groups. Based on these results,
it appears that AA HUVECs were more susceptible to the
damaging effects of TNF-α. Plasma TNF-α concentrations
have been associated with early atherosclerosis.50 Moreover,
there are reports that African Americans have higher systemic levels of inflammatory biomarkers16–21 which suggests
that at least a portion of their endothelial dysfunction may
be secondary to cytokine-induced endothelial activation/
apoptosis.
The endothelium has several important functions related
to cardiovascular health. Functional changes of the activated
endothelium include disturbance of the regulation of vessel
tone and the maintenance of a vascular environment that
favors coagulation, inflammation, and atherosclerosis. EMP
levels are increased in hypertension and a significant correlation was shown between EMP and blood pressure.46 It is
thought that African Americans have lower endothelial NO
bioavailability than Caucasians based on findings of attenuated flow-mediated arterial vasodilatation.4–6 Other investigations have also documented lower endothelial-dependent
vasodilation in African Americans.8–11,51,52
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TNF-α can induce endothelial dysfunction through both
inflammatory and oxidative stress mechanisms. TNF-α
activates the p38 MAPK pathway53 and the transcription
factor, NF-κB, which regulates the expression of genes
involved in inflammation, oxidative stress, and endothelial
dysfunction.54–56 Inflammatory cytokines induce the expression of adhesion molecules and chemoattractants by ECs.
Gertzberg et al and Yamagishi et al showed that in response
to TNF-α, EC NADPH oxidase activity increased, leading
to increased O2- production.57,58 Under normal physiological
conditions, the dismutation of O2- by SOD yields H2O2. In the
case of heightened NADPH oxidase activity and O2- overproduction, O2- reacts with NO to produce ONOO- thus reducing NO bioavailability.59 In order to assess the potential for
O2- dismutation in the present study, total SOD activity was
measured in cell lysate from both basal and TNF-α stimulated
AA and Caucasian HUVECs. We observed significantly
higher SOD activity in the Caucasian HUVECs under both
conditions. The AA HUVECs had a 79% increase in SOD
activity compared to a 50% increase in Caucasian HUVECs.
This could suggest a higher oxidative stress response to the
TNF-α stimulation which is also evidenced by the heightened EMP production with TNF-α stimulation in the African
American HUVECs.
In the present study, we also measured EMP levels after
incubation of the HUVECs with SOD alone and after incubation with TNF-α + SOD. The response to SOD alone was
similar in both groups of HUVECs. Though both the AA and
Caucasian HUVECs showed a significant decrease in EMP
levels when the TNF-α + SOD condition was compared to
the TNF-α alone condition, the AA HUVECs showed a 68%
decrease in EMP levels whereas the Caucasian HUVECs
showed a 35% decrease in EMP level. These results suggest
that TNF-α-induced oxidative stress played a greater role in
EMP generation in AA compared to Caucasian HUVECs
because the effect of SOD was nearly twice that of the
Caucasian HUVECs.
The proinflammatory cytokine TNF-α also induces
EC gene expression and production of IL-6 via the NF-κB
pathway.58 IL-6 is a secondary inflammatory cytokine that
mediates the regulation of the acute-phase response to injury
and infection. IL-6 induces the increase of plasma concentrations of fibrinogen, PAI-1, and CRP. Evidence indicates
that the elevation of CRP predicts future cardiovascular
events.60
In the present study, we observed that the AA HUVECs
had nearly a two-fold greater basal IL-6 concentration
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compared to the Caucasian HUVECs. Western blot analysis of basal IL-6 expression showed that the AA HUVECs
had significantly greater IL-6 protein expression. The IL-6
response to SOD was also different between the HUVEC
groups. SOD decreased IL-6 concentration in the AA
HUVECs but increased IL-6 concentration in the Caucasian
HUVECs. The reasons for the disparate IL-6 response to SOD
are not clear. Incubating the HUVECs with TNF-α + SOD
similarly decreased IL-6 concentrations compared to incubation with TNF-α alone. These changes were similar in both
HUVEC groups. In healthy men, elevated levels of IL-6 were
associated with increased future CVD risk, endothelial dysfunction, and hypertension.61–63 Epidemiologic data support
the existence of an association between different inflammatory markers and high blood pressure.64,65
The normal functional integrity of ECs is maintained
by continuous cell regeneration and the incorporation of
endothelial progenitor cells. Under these normal quiescent
conditions, EC activation tends to be localized, low-grade,
and reversible. The level of circulating EMP is very low
when ECs are quiescent.66 The exposure of the endothelium
to cytokines causes vascular inflammation by inducing EC
activation and apoptosis. There is a tendency for African
Americans to have heightened systemic inflammation as measured by various inflammatory biomarkers.16–21 Long-term
exposure of the endothelium to proinflammatory cytokines
leads to increased oxidative stress, inflammation, and apoptosis, and promotes leukocyte infiltration and thrombosis.
All of these changes to ECs cause vascular dysfunction
and support an EC environment favoring hypertension and
atherosclerosis.
The aim of this observational study was to assess ECs
that have not been exposed to chronic diseases in order to
assess their fundamental response to stimuli. The HUVECs
were purchased from Lonza Inc in which only the racial
origin is known, due to The Health Insurance Portability and
Accountability Act, which protects the privacy of individually
identifiable health information. HUVECs are derived from
fetal tissue which makes them better suited for measuring
fundamental responses to stimuli because adult ECs may
have been subjected to prolonged exposure to cytokines, hormones, and other stimuli, potentially resulting in an altered
phenotype.67 An EC obtained from a newborn has already
developed to the point where it is suitable for its particular
function. One study found that out of the potentially confounding variables such as the interval between delivery and
cell isolation, sex and weight of newborn, type of delivery,
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age, smoking habits, diabetes, or hypertension of the mother,
only the short time between delivery and cell isolation and
the mother’s smoking habits lead to alterations in cell culture
success rate68 and morphology.69 Thus while we do not know
the specific characteristics of the mothers, we believe that the
HUVECs were relatively unaffected by the mother.
There are several limitations of the study that are worth
noting. First, we did not directly measure the levels of the
superoxide radical. The measurement of total SOD activity provides insight into the cell’s potential for superoxide
quenching. Second, we only incubated the cells with TNF-α
for 4 hours. This was done in order to avoid significant
apoptosis. Lastly, the present observational study cannot
provide insight into potential mechanisms for heightened EC
susceptibility to TNF-α in AA HUVECs but it may lie in differences in TNF-α receptor sensitivity and/or post-receptor
signaling mechanisms.
The preliminary results of our study suggest that AA
HUVECs are more susceptible to the injurious effects of the
proinflammatory cytokine, TNF-α. In addition, the results
suggest that TNF-α-induced oxidative stress plays a greater
role in EMP generation in AA compared to Caucasian
HUVECs. If African Americans tend to have a subclinical
heightened state of chronic systemic low-grade inflammation,
then the manner in which their ECs respond to inflammatory
cytokines could make them more susceptible to long-term
endothelial dysfunction and its sequelae such as hypertension and atherosclerosis. This warrants the importance of
aggressive preventive lifestyle modification strategies in
African Americans in early subclinical stages of hypertension development to reduce the inflammation and oxidative
stress burdens.
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